Next-generation DNA sequencing identifies mutated FANCD2 Gene as a novel Biomarker for monitoring early disease progression and timely therapeutic interventions in advanced phase Chronic Myeloid Leukemia patients
Year: 2023
Type: preprint
Study design: Observational Study
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4669219
Authors: Nawaf Alanzazi, Abdulaziz Siyal, Muhammad Absar, Masood Shammas, Sarah AlMukhaylid, Amer Mahmood, Zafar Iqbal
Institutions: King Abdulaziz Hospital, King Abdulaziz Hospital, King Saud University, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, King Saud bin Abdulaziz University for Health Sciences, University of the Punjab, King Abdulaziz Medical City, Qarshi University, King Abdullah International Medical Research Center, National Guard Health Affairs
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4389960907